Cargando…

PT578. Endothelial-monocyte-activating polypeptide-2 (EMAP-2) may be a novel treatment target of Alzheimer’s disease

Detalles Bibliográficos
Autores principales: Jang, Sooah, Jeong, Jihyeon, Kim, Eosu, Kim, Chul Hoon, Namkoong, Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616912/
http://dx.doi.org/10.1093/ijnp/pyw044.578
_version_ 1783266894695890944
author Jang, Sooah
Jeong, Jihyeon
Kim, Eosu
Kim, Chul Hoon
Namkoong, Kee
author_facet Jang, Sooah
Jeong, Jihyeon
Kim, Eosu
Kim, Chul Hoon
Namkoong, Kee
author_sort Jang, Sooah
collection PubMed
description
format Online
Article
Text
id pubmed-5616912
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56169122017-11-27 PT578. Endothelial-monocyte-activating polypeptide-2 (EMAP-2) may be a novel treatment target of Alzheimer’s disease Jang, Sooah Jeong, Jihyeon Kim, Eosu Kim, Chul Hoon Namkoong, Kee Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616912/ http://dx.doi.org/10.1093/ijnp/pyw044.578 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Jang, Sooah
Jeong, Jihyeon
Kim, Eosu
Kim, Chul Hoon
Namkoong, Kee
PT578. Endothelial-monocyte-activating polypeptide-2 (EMAP-2) may be a novel treatment target of Alzheimer’s disease
title PT578. Endothelial-monocyte-activating polypeptide-2 (EMAP-2) may be a novel treatment target of Alzheimer’s disease
title_full PT578. Endothelial-monocyte-activating polypeptide-2 (EMAP-2) may be a novel treatment target of Alzheimer’s disease
title_fullStr PT578. Endothelial-monocyte-activating polypeptide-2 (EMAP-2) may be a novel treatment target of Alzheimer’s disease
title_full_unstemmed PT578. Endothelial-monocyte-activating polypeptide-2 (EMAP-2) may be a novel treatment target of Alzheimer’s disease
title_short PT578. Endothelial-monocyte-activating polypeptide-2 (EMAP-2) may be a novel treatment target of Alzheimer’s disease
title_sort pt578. endothelial-monocyte-activating polypeptide-2 (emap-2) may be a novel treatment target of alzheimer’s disease
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616912/
http://dx.doi.org/10.1093/ijnp/pyw044.578
work_keys_str_mv AT jangsooah pt578endothelialmonocyteactivatingpolypeptide2emap2maybeanoveltreatmenttargetofalzheimersdisease
AT jeongjihyeon pt578endothelialmonocyteactivatingpolypeptide2emap2maybeanoveltreatmenttargetofalzheimersdisease
AT kimeosu pt578endothelialmonocyteactivatingpolypeptide2emap2maybeanoveltreatmenttargetofalzheimersdisease
AT kimchulhoon pt578endothelialmonocyteactivatingpolypeptide2emap2maybeanoveltreatmenttargetofalzheimersdisease
AT namkoongkee pt578endothelialmonocyteactivatingpolypeptide2emap2maybeanoveltreatmenttargetofalzheimersdisease